TipRanks Financial Blog Nymox Pharmaceuticals (NASDAQ: NYMX) tanked in pre-market trading at the time of writing on Thursday after the company received a potential Nasdaq delisting notice....\n more…
SeekingAlpha.com: All News Nymox Pharmaceutical (NYMX) informed shareholders on Wednesday that it has received a delisting determination letter from Nasdaq on failing to regain with the minimum bid...\n more…
Globe Newswire IRVINE, Calif., July 05, 2023 (GLOBE NEWSWIRE) -- Nymox Pharmaceutical Corporation (NASDAQ: NYMX) (the Company) today received a Nasdaq Hearing Delist Decision, noting that Nymox has not regained the required $1.00 share price within the 6-month extension period granted by Nasdaq, and hence the ...\n more…
Ticker Report StockNews.com began coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Free Report) in a research report report published on Monday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Up 37.8 % Shares of NASDAQ NYMX opened at...\n more…
Zolmax StockNews.com started coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Get Rating) in a research note issued on Sunday. The brokerage set a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Performance NYMX opened at $0.33 on Friday. The firms 50-day simple ...\n more…
Ticker Report StockNews.com started coverage on shares of Nymox Pharmaceutical (NASDAQ:NYMX Get Rating) in a research report sent to investors on Sunday morning. The firm issued a sell rating on the biopharmaceutical companys stock. Nymox Pharmaceutical Stock Performance NYMX opened at $0.32 on ...\n more…